255
Views
9
CrossRef citations to date
0
Altmetric
REVIEW ARTICLE

History and current status of Plasmodium falciparum antimalarial drug resistance in Madagascar

, , &
Pages 22-32 | Received 25 Jun 2009, Accepted 24 Aug 2009, Published online: 08 Jan 2010

References

  • Willcox ML, Rakotondrazafy E, Andriamanalimanana R, Andrianasolo D, Rasoanaivo P. Decreasing clinical efficacy of chloroquine in Ankazobe, Central Highlands of Madagascar. Trans R Soc Trop Med Hyg 2004;98:311–4.
  • Robert V, Le Goff G, Andrianaivolambo L, Randimby FM, Domarle O, Randrianarivelojosia M, . Moderate transmission but high prevalence of malaria in Madagascar. Int J Parasitol 2006;36:1273–81.
  • Romi R, Razaiarimanga MC, Raharimanga R, Rakotondraibe EM, Ranaivo LH, Pietra V, . Impact of the malaria control campaign (1993–1998) in the highlands of Madagascar: parasitological and entomological data. Am J Trop Med Hyg. 2002;66:2–6.
  • Bernard PM. Trois ans de lutte antipaludique à Madagascar (1950–1951–1952). Bull Madagascar. 1954;96:415–20.
  • Joncour G. The fight against malaria in Madagascar. Bull World Health Organ. 1956;15:711–23.
  • Blanchy S, Rakotonjanabelo A, Ranaivoson G, Rajaonarivelo E. Epidémiologie du paludisme sur les hautes terres malgaches depuis 1878. Santé. 1993;3:155–61.
  • Lepers JP, Deloron P, Fontenille D, Coulanges P. Reappearance of falciparum malaria in central highland plateaux of Madagascar. Lancet. 1988;1:586–
  • Mouchet J, Laventure S, Blanchy S, Fioramonti R, Rakotonjanabelo A, Rabarison P. The reconquest of the Madagascar highlands by malaria. Bull Soc Pathol Exot. 1997;90:162–8.
  • Coulanges P, Le Bras J, Deloron P, Ramanamirija JA, Biaud JM, Marchais H. In vivo and in vitro study of the chemosensitivity of Plasmodium falciparum in Madagascar, 1982–1986. Arch Inst Pasteur Madagascar. 1987;53:63–76.
  • Ministère de la Santé, du Planning Familial. Protection Sociale. Plan stratégique de lutte contre le paludisme, du contrôle vers l'élimination du paludisme à Madagascar. Madagascar: Ministry of Health; 2007. 54.
  • Mouchet J, Carnevale P, Coosemans M, Julvez J, Manguin S, Richard-Lenoble D, . Iles du sud-ouest de l'océan Indien. In: Libbey J, . Biodiversité du paludisme dans le monde. Paris: Eurotext; 2004. 167–74.
  • Hewitt R, Krause A, Goldman A, Campbell G, Jenkins T. β-Globin haplotype analysis suggests that a major source of Malagasy ancestry is derived from Bantu-speaking negroids. Am J Hum Genet. 1996;58:1303–8.
  • Goasguen J, Gentelet B, Moreau J, Fouquet R, Coulanges P. Plasmodium falciparum chloroquino-résistant? A propos des deux premiers cas malgaches. Arch Inst Pasteur Madagascar. 1975;44:143–5.
  • Aronsson B, Bengtsson E, Bjorkman A, Pehrson PO, Rombo L, Wahlgren M. Chloroquine-resistant falciparum malaria in Madagascar and Kenya. Ann Trop Med Parasitol. 1981;75:367–73.
  • World Health Organization. World malaria report. Geneva: WHO; 2008. Available at: http://malaria.who.int/wmr2008/MAL2008-CountryProfiles/MAL2008-Madagascar-EN.pdf accessed September 2009).
  • Barnadas C, Tichit M, Bouchier C, Ratsimbasoa A, Randrianasolo L, Raherinjafy R, . Plasmodium vivax dhfr and dhps mutations in isolates from Madagascar and therapeutic response to sulfadoxine–pyrimethamine. Malar J. 2008;7:35–
  • Barnadas C, Ratsimbasoa A, Ranaivosoa H, Ralaizandry D, Raveloariseheno D, Rabekotonorina V, . Short report: prevalence and chloroquine sensitivity of Plasmodium malariae in Madagascar. Am J Trop Med Hyg. 2007;77:1039–42.
  • Mouchet J, Blanchy S, Rakotonjabelo A, Ranaivoson G, Rajaonarivelo E, Laventure S, . Epidemiological stratification of malaria in Madagascar. Arch Inst Pasteur Madagascar. 1993;60:50–9.
  • Blanchy S, Rakotonjanabelo A, Ranaivoson G. Surveillance épidémiologique du paludisme instable. Santé. 1993;3:247–55.
  • Ménard D, Randrianarivo-Solofoniaina AE, Ahmed BS, Jahevitra M, Andriantsoanirina V, Rasolofomanana JR, . Drug-resistant malaria parasites introduced into Madagascar from Comoros Islands. Emerg Infect Dis. 2007;13:1759–62.
  • Razanamparany MS, Randriamiharisoa FA, Razanamparany NJ, Ramialimanana V. The malaria epidemic in Antananarivo from 1983 to 1994 as seen through the Pediatric Service A in the Befelatanana General Hospital. Santé. 1995;5:382–5.
  • Razanamparany M, Bosman A, Ravelomanana N, Randriamiharisoa F, Razafimantsoa L. The malaria epidemic in Antananarivo observed from Pediatric Service ‘A’ of the Befelatanana General Hospital. Parassitologia. 1989;31:89–99.
  • Ratsimbasoa A, Randrianarivelojosia M, Millet P, Soarès JL, Rabarijaona L, Rakotoson B, . Use of pre-packaged chloroquine for the home management of presumed malaria in Malagasy children. Malar J. 2006;5:79–
  • Randrianarivelojosia M, Raharimalala LA, Randrianasolo L, Ratsimbasoa A, Rason MA, Ariey F, . Madagascan isolates of Plasmodium falciparum showing low sensitivity to artemether in vitro. Ann Trop Med Parasitol. 2001;95:237–43.
  • Talisuna AO, Bloland P, D’Alessandro U. History, dynamics, and public health importance of malaria parasite resistance. Clin Microbiol Rev. 2004;17:235–54.
  • Deloron P, Ramanamirija JA, Verdíer F, Coulanges P. 4-Aminoquinoline-sensitivity of Plasmodium falciparum in Madagascar. II. Study in two regions of the east coast. Arch Inst Pasteur Madagascar. 1984;51:43–55.
  • Biaud JM, Ramanamirija JA, Ramiliarisoa O, Verdier F, Coulanges P, Le Bras J. Drug sensitivity of malaria in Madagascar. Comparison in vivo and in vitro of the effects of chloroquine and amodiaquine on Pfalciparum in 1984. Arch Inst Pasteur Madagascar. 1985;52:73–84.
  • Marchais H, Ramanamirija JA, Le Bras J, Coulanges P. In vivo and in vitro sensitivity to 4-aminoquinolines of Plasmodium falciparum in Madagascar: results of a study conducted on the east coast (July 1985–July 1986). Arch Inst Pasteur Madagascar. 1987;53:43–62.
  • Coulanges P, Le Bras J, Deloron P, Ramanamirija JA. Resistance of Plasmodium falciparum to 4-aminoquinolines. A review based on the Madagascar experience. Arch Inst Pasteur Madagascar. 1987;53:77–103.
  • Lepers JP, Ramanamirija JA, Randriasamimanana JR, Ramanandraibe LM, Rahelimalala RS, Rene JP, . Malaria in Ile de Sainte Marie in 1988. Epidemiological approach Chloroquine sensitivity of Plasmodium falciparum. Arch Inst Pasteur Madagascar. 1989;56:131–42.
  • Lepers JP, Deloron P, Andriamangatiana-Rason MD, Ramanamirija JA, Coulanges P. Sensitivity of Plasmodium falciparum to different antimalarials. A study in 1988 in a village in the Hauts-Plateaux of Madagascar. Bull Soc Pathol Exot. 1989;82:650–7.
  • Andriamangatiana-Rason MD, Lepers JP, Raharimalala Andrianavalona L, Verdier F, Coulanges P. Aspects of in vivo chemosensitivity of Plasmodium falciparum to chloroquine in a village of the highland plateaux of Madagascar in 1989. Arch Inst Pasteur Madagascar. 1990;57:93–104.
  • Lepers JP, Deloron P, Mouden JC, Le Bras J, Coulanges P. Sudden increase in number of isolates of Plasmodium falciparum resistant to chloroquine in Madagascar. Trans R Soc Trop Med Hyg. 1989;83:491–2.
  • Blanchy S, Rakotonjanabelo A, Ranaivoson G. Evolution of Plasmodium falciparum drug sensitivity in Madagascar from 1982 to 1993 and operational consequences. Bull Soc Pathol Exot. 1993;86:254–9.
  • Ringwald P, Rabarison P, Raharimalala L, Rason MD, Lepers JP, Le Bras J, . Stability and chemosensitivity of Plasmodium falciparum to chloroquine in 1990 and 1991 in Ankazobe, a village in high plateau Madagascar. Bull Soc Pathol Exot. 1992;85:219–22.
  • Randrianarivelojosia M, Raharimalala L, Randriamanantena A, Jambou R. Drug resistance of Plasmodium falciparum in coastal regions of Madagascar. Med Trop. 2000;60:243–9.
  • Ménard D, Ratsimbasoa A, Randrianarivelojosia M, Rabarijaona LP, Raharimalala L, Domarle O, . Assessment of the efficacy of antimalarial drugs recommended by the National Malaria Control Programme in Madagascar: updated baseline data from randomized and multi-site clinical trials. Malar J. 2008;7:55–
  • Rakoto SA, Raharimalala L, Jambou R. Etude de la chimiosensibilité de Plasmodium falciparum à Madagascar : 1 – situation des médicaments de seconde ligne à Taolagnaro (quinine, sulfadoxine–pyrimeéthamine). Arch Inst Pasteur Madagascar. 1998;64:51–5.
  • Randrianarivelojosia M, Ariey F, Raharimalala LA, Parzy D, Rogier C, Jambou R. Current absence of pyrimethamine resistance of Plasmodium falciparum in Madagascar. Trans R Soc Trop Med Hyg. 2002;96:557–9.
  • Randrianasolo L, Randriamanantena A, Ratsimbasoa A, Rakotoson JD, Randriambelosoa J, Raveloson A, . Surveillance de l’efficacité de sulfadoxine–pyrimeéthamine (Fansidar®, Paludar®) pour le traitement de l’accés palustre à Madagascar : proposition d'un protocole simplifié. Arch Inst Pasteur Madagascar. 2003;69:52–6.
  • Randrianasolo L, Randriamanantena A, Ranarivelo L, Ratsimbasoa A, Domarle O, Randrianarivelojosia M. Monitoring susceptibility to sulfadoxine–pyrimethamine among cases of uncomplicated Plasmodium falciparum malaria in Saharevo, Madagascar. Ann Trop Med Parasitol. 2004;98:551–4.
  • Randriamanantena A, Randrianasolo L, Vonimpaisomihanta JA, Tafangy PB, Bayant Z, Randrianarivelojosia M. Therapeutic efficacy of amodiaquine against uncomplicated malaria in Madagascar. Santé. 2007;17:75–8.
  • Deloron P, Le Bras J, Ramanamirija JA, Coulanges P. Plasmodium falciparum in Madagascar: in vivo and in vitro sensitivity to seven drugs. Ann Trop Med Parasitol. 1985;79:357–65.
  • Deloron P, Lepers JP, Verdier F, Chougnet C, Remanamirija JA, Andriamangatiana-Rason MD, . Efficacy of a 3-day oral regimen of a quinine–quinidine–cinchonine association (Quinimax) for treatment of falciparum malaria in Madagascar. Trans R Soc Trop Med Hyg. 1989;83:751–4.
  • Rason MA, Andrianantenaina HB, Ariey F, Raveloson A, Domarle O, Randrianarivelojosia M. Prevalent pfmdr1 N86Y mutant Plasmodium falciparum in Madagascar despite absence of pfcrt mutant strains. Am J Trop Med Hyg. 2007;76:1079–83.
  • Randrianarivelojosia M, Randrianasolo L, Randremanana RV, Randriamanantena A, Ratsimbasoa A, Rakotoson JD. Susceptibility of Plasmodium falciparum to the drugs used to treat severe malaria (quinine) and to prevent malaria (mefloquine, cycloguanil) in Comoros Union and Madagascar. S Afr Med J. 2004;94:47–51.
  • Randrianarivelojosia M, Sahondra-Harisoa JL, Raharimalala LA, Raveloson A, Mauclère P, Ariey F. A network RER rooted on in vitro readout assays of Plasmodium falciparum sensitivity to chloroquine in the Indian Ocean region. Santé. 2003;13:95–100.
  • Randrianarivelojosia M, Harisoa JL, Rabarijaona LP, Raharimalala LA, Ranaivo L, Pietra V, . In vitro sensitivity of Plasmodium falciparum to amodiaquine compared with other major antimalarials in Madagascar. Parassitologia. 2002;44:141–7.
  • Randrianarivelojosia M, Rakotonjanabelo LA, Mauclère P, Ratsimbasoa A, Raharimalala LA, Ariey F. National network study to perpetuate the surveillance of Plasmodium falciparum sensitivity to antimalarials in Madagascar. Arch Inst Pasteur Madagascar. 2002;68:73–8.
  • Randrianarivelojosia M, Ratsimbasoa A, Randrianasolo L, Randrianarijaona A, Jambou R. In-vitro sensitivity of Plasmodium falciparum to chloroquine, halofantrine, mefloquine and quinine in Madagascar. East Afr Med J. 2002;79:237–41.
  • Raharimalala AL, Randrianarivelojosia M, Randriamanantena A, Ranarivelo LA, Jaureguiberry S, Rason MA, . Chemosensitivity of Plasmodium falciparum in Sainte Marie island, east coast of Madagascar: in vivo and in vitro studies. Arch Inst Pasteur Madagascar. 2000;66:26–31.
  • Rason MA, Ariey F, Rafidimanantsoa L, Andrianantenaina BH, Sahondra Harisoa JL, Randrianarivelojosia M. Monitoring the drug-sensitivity of Plasmodium falciparum in coastal towns in Madagascar by use of in vitro chemosensitivity and mutation detection tests. Parasite. 2002;9:247–53.
  • Milijaona R, Jambou R, Raharimalala L, Ranaivo L, Rason MA, Roux J. Mefloquine-resistant strains of Plasmodium falciparum in Madagascar: impact on tourists and public health. Ann Trop Med Parasitol. 2000;94:313–7.
  • Milijaona R, Raharimalala L, Ramambanirina L, Ranaivo LH, Jambou R. Drug resistance of Plasmodium falciparum along the borders of the highlands in Madagascar: outlook for a national control program. Med Trop. 1998;58:261–5.
  • Lepers JP, Ramanamirija JA, Rason MD, Coulanges P. In vitro sensitivity of Plasmodium falciparum to chloroquine in the highland region of Madagascar in 1987. Bull Soc Pathol Exot. 1988;81:338–44.
  • Ramanamirija JA, Deloron P, Biaud JM, Le Bras J, Coulanges P. In vivo and in vitro sensitivity to 4-aminoquinolines of Plasmodium falciparum in Madagascar: results of 2 years’ study. Bull Soc Pathol Exot. 1985;78:606–14.
  • Deloron P, Ramanamirija JA, Le Bras J, Coulanges P. 4-Aminoquinoline-sensitivity of Plasmodium falciparum in Madagascar III Studies in three regions of the interior. Arch Inst Pasteur Madagascar. 1984;51:57–68.
  • Deloron P, Ramanamirija JA, Le Bras J, Verdier P, Coulanges P. 4-Aminoquinoline-sensitivity of Plasmodium falciparum in Madagascar. I. Study in two regions of the west coast. Arch Inst Pasteur Madagascar. 1984;51:29–42.
  • Le Bras J, Dulat C, Coulanges P, Ralamboson D, Rakotonirina-Randriambeloma PJ, Deloron P. Preliminary in vitro study of drug sensitivity of Plasmodium falciparum in Madagascar. Arch Inst Pasteur Madagascar. 1982;50:15–22.
  • Raharimalala L, Lepers JP, Lepers-Rason MD, Rabarison P, Ramambanirina L, Roux J. Aspects of Plasmodium falciparum sensitivity to chloroquine in Madagascar from 1982 to 1993. Arch Inst Pasteur Madagascar. 1993;60:60–4.
  • Ariey F, Fandeur T, Durand R, Randrianarivelojosia M, Jambou R, Legrand E, . Invasion of Africa by a single pfcrt allele of South East Asian type. Malar J. 2006;5:34–
  • Ariey F, Randrianarivelojosia M, Duchemin JB, Rakotondramarina D, Ouledi A, Robert V, . Mapping of a Plasmodium falciparum pfcrt K76T mutation: a useful strategy for controlling chloroquine resistance in Madagascar. J Infect Dis. 2002;185:710–2.
  • Randrianarivelojosia M, Fidock DA, Belmonte O, Valderramos SG, Mercereau-Puijalon O, Ariey F. First evidence of pfcrt mutant Plasmodium falciparum in Madagascar. Trans R Soc Trop Med Hyg. 2006;100:826–30.
  • Picot S, Olliaro P, de Monbrison F, Bienvenu AL, Price RN, Ringwald P. A systematic review and meta-analysis of evidence for correlation between molecular markers of parasite resistance and treatment outcome in falciparum malaria Malar J. 2009;8:89–
  • Ménard D, Andriantsoanirina V, Jahevitra M, Barnadas C, Tichit M, Bouchier C, . Dihydrofolate reductase I164L mutation in Plasmodium falciparum, Madagascar. Emerg Infect Dis. 2008;14:1166–7.
  • Hastings IM, Korenromp EL, Bloland PB. The anatomy of a malaria disaster: drug policy choice and mortality in African children. Lancet Infect Dis. 2007;7:739–48.
  • Randrianarivelojosia M, Raveloson A, Randriamanantena A, Juliano JJ, Andrianjafy T, Raharimalala LA, . Lessons learnt from the six decades of chloroquine use (1945–2005) to control malaria in Madagascar. Trans R Soc Trop Med Hyg. 2009;103:3–10.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.